Nitrofurantoin Monohydrate/ Macrocrystalline
NDC Package 70934-047-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Nitrofurantoin Monohydrate/ Macrocrystalline is a . Marketed by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, this product is identified by NDC 70934-047 and is authorized under FDA application NDA020064.

Identification & Billing

NDC Package Code
70934-047-10
Package Description
10 CAPSULE in 1 BOTTLE, PLASTIC
Product Code
11-Digit Billing Format
70934004710

Clinical Specifications

Proprietary Name
Nitrofurantoin Monohydrate/ Macrocrystalline
Dosage Form
-

Regulatory & Marketing

Labeler Name
Denton Pharma, Inc. Dba Northwind Pharmaceuticals
FDA Application #
NDA020064
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
11-27-2017
End Marketing Date
07-31-2024
Listing Expiration
07-31-2024
Exclude Flag
D
Sample Package
No

Hierarchy Structure

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (70934-047). Click a package code to view its specific billing and regulatory data.

14 CAPSULE in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70934-047-10 identifies a specific commercial package of 10 capsule in 1 bottle, plastic of Nitrofurantoin Monohydrate/ Macrocrystalline, labeled by Denton Pharma, Inc. Dba Northwind Pharmaceuticals. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Denton Pharma, Inc. Dba Northwind Pharmaceuticals on November 27, 2017. The current certification is valid through July 31, 2024.

How is this Denton Pharma, Inc. Dba Northwind Pharmaceuticals product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70934004710. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70934-047-10
11-Digit CMS (5-4-2)
70934-0047-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.